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Maternal vitamin D deﬁciency during pregnancy is a recog-
nized risk factor for rickets and osteomalacia in infancy (1).
The circulating plasma concentration of 25-hydroxyvitamin
D (25OHD), a long-lived metabolite of vitamin D, is used to
judge vitamin D status; values below 25 nmol⁄L are asso-
ciated with an increased risk of rickets and osteomalacia
(1). There is evidence that a low maternal plasma 25OHD
in pregnancy may inﬂuence the growth and bone mineral
accrual of the offspring during foetal life, infancy and child-
hood. Positive associations have been reported between
maternal vitamin D status in pregnancy and birthweight,
birth length, length at 1 year and bone mineral accretion at
9 years (2–6), although evidence is conﬂicting (7,8). These
relationships have been observed at concentrations of
25OHD higher than those associated with rickets and
osteomalacia, and there are calls to raise the accepted lower
threshold of vitamin D sufﬁciency for pregnant women,
most recently to 80 nmol⁄L (9). On a population basis,
plasma 25OHD concentrations above 80 nmol⁄L are rela-
tively uncommon in countries at temperate latitudes but are
more common among people living in the tropics who have
abundant skin sunshine exposure (10). To contribute to the
debate on the deﬁnition of vitamin D sufﬁciency in preg-
nancy, we have investigated the inﬂuence of maternal
plasma 25OHD concentration on foetal and infant growth
in a rural area of The Gambia, West Africa (13 N). In this
region, there is tropical sunshine all year, the women are
farmers who work out-of-doors for much of each day, and
local female dress does not restrict regular sunshine
exposure to the face, neck, shoulders, arms and feet, espe-
cially during farm work and gardening.
The study was a secondary analysis of biochemical, an-
thropometric and bone data from a subset of 125 women and
infants collected during a calcium supplementation study of
blood pressure in pregnant Gambian women (International
Trial Registry: ISRCTN96502494). No signiﬁcant beneﬁts
for foetal and infant growth of maternal calcium supplemen-
tation were identiﬁed despite the low customary calcium
intake in The Gambia (11). The protocol, methods, mater-
nal characteristics and infant data from the detailed study
have been published (11). Brieﬂy, women from the rural
villages of Keneba and Manduar, West Kiang, The Gambia
were recruited at 20 weeks of pregnancy (P20) and rando-
mized to a daily calcium supplement or a matching pla-
cebo tablet until parturition (1500 mg Ca as calcium
carbonate and microcellulose-lactose, respectively;
Nycomed Pharma AS, Asker, Norway). Fasting, early
morning blood was collected and anthropometry per-
formed at P20 and 36 weeks of pregnancy (P36). The mean
(± SD) age, weight, height and dietary calcium intake of
the women at P20 were 27.4 ± 7.5 years, 56.3 ± 6.7 kg,
1.61 ± 0.05 m and 356 ± 190 mg⁄day, respectively. The
median parity (range) was 3 (0–10). Infant birthweight was
measured within 24 h of delivery. Weight, crown-heel
length and head circumference were measured at 2, 13 and
52 weeks postpartum. In addition, infant bone mineral
content (BMC), bone mineral density (BMD) and bone
width (BW) or bone area (BA), were measured by single
Acta Pædiatrica ISSN 0803–5253
1360 ª2009 MRC Human Nutrition Research/Journal Compilation ª2009 Foundation Acta Pædiatrica/Acta Pædiatrica 2009 98, pp. 1360–1362photon absorptiometry of the midshaft radius (Lunar SP2,
Lunar Corporation, Madison, WI, USA) and, for a subset
(n ¼ 44, 47 and 52 at 2, 13 and 52 weeks, respectively), by
whole-body dual-energy X-ray absorptiometry (Lunar
DPX+, software version 4.7b, Lunar Corporation).
Plasma 25OHD was measured a using radioimmunomet-
ric assay (Diasorin Ltd, Wokingham, Berks, UK), with
assay performance monitored through the Vitamin D External
Quality Assessment Scheme (DEQAS; Endocrine⁄Oncology
Laboratory, Charing Cross Hospital, London, UK). The
intra- and inter-assay coefﬁcients of variation were 4% and
<6%, respectively. Relationships between infant outcomes
and maternal 25OHD concentration were explored using
multiple linear regressions (DataDesk 6.2.1, Data Descrip-
tion Inc., Ithaca, NY, USA). The following potential con-
founders were included in the full models: maternal weight,
weight gain, height, parity, supplement group, sex of infant
and season. Nonsigniﬁcant variables were removed by
backwards elimination to produce parsimonious models.
Infant BMC was corrected for bone and body size by includ-
ing infant weight, length and BW or BA, in the regression
models (12). An interaction term, supplement group ·
25OHD, was added to investigate potential synergistic
effects of calcium supplementation and maternal vitamin D
status on infant growth outcomes. Other analyses of mater-
nal 25OHD included comparisons between P20 and P36,
and also as outcomes the proportions above and below the
cut-off of 80 nmol⁄L. A conservative level of signiﬁcance of
p £ 0.01 was adopted in recognition of the large number of
separate statistical tests performed (>100); possible trends
in the data with p ¼ 0.01–0.1 were noted. The analysis was
conducted on 123 mother–infant pairs; blood samples from
two subjects were not available.
Mean ± SD 25OHD (range) was: P20 ¼ 103 ± 25 (53–
167) nmol⁄L; P36 ¼ 111 ± 27 (51–189) nmol⁄L. No subject
had a 25OHD value <50 nmol⁄L, 20% and 16% had 25OHD
<80 nmol⁄L, at P20 and P36, respectively. There was a high
degree of within-subject consistency in 25OHD at P20 and
P36 (25OHDP36 ¼ 33.2 + [0.79 ± 0.07] · 25OHDP20,p£
0.001, R
2 adjusted 51.5%, n ¼ 121); 11% of women had
25OHD <80 nmol⁄L at both P20 and P36. The mean birth-
weight of the infants was 2.99 ± 0.36 kg. The infant anthro-
pometric and bone measures during the ﬁrst year are given
in Table 1. No signiﬁcant relationships or trends in the data
were observed between maternal 25OHD concentration
using the values at P20, P36 or the mean of the two and any
of the following infant measures: birthweight, infant weight,
length, head circumference, BMC, BW (or BA), BMD and
size-adjusted BMC of the midshaft radius and whole body at
any time postpartum. This is illustrated in Figure 1 for birth-
weight as a function of maternal 25OHD concentration at
P20. Comparing the results for mothers with 25OHD above
and below 80nmol⁄L didnotalter this ﬁnding.
No signiﬁcant interaction between supplement group and
maternal 25OHD concentration was observed for any infant
variable. Trends in the data were observed in a few instances
for a supplement group · 25OHD interaction among the
bone measures but no consistent picture emerged and they
were consideredto have arisen by chance.
We conclude that there is no evidence for an inﬂuence of
vitamin D status during pregnancy on infant growth and
bone mineral accrual in the conditions prevailing in The
Gambia. The children in this study, as is common in this
region of The Gambia (13), were born small, grew well for
the ﬁrst months of life but experienced growth faltering dur-
ing later infancy compared to Western children (11,14), as
demonstrated by their weight and length SDS. The 25OHD
concentrations of the women were >50 nmol⁄L in the sec-
ond half of pregnancy, and no distinction could be drawn in
infant outcomes between mothers with concentrations
above or below 80 nmol⁄L. Thus, our study suggests that,
for women with regular, adventitious UVB sunshine expo-
sure and in situations where foetal and infant growth may
Table 1 Anthropometric and bone measures of Gambian infants
Characteristic
Age (weeks)
2( n¼ 125) 13 (n ¼ 123) 52 (n ¼ 121)
Weight (kg) 3.32 ± 0.47 5.84 ± 0.72 8.08 ± 0.97
Length (cm) 50.5 ± 1.9 59.6 ± 2.0 71.9 ± 2.8
Head circumference
(cm) 35.5 ± 1.6 40.0 ± 1.3 44.6 ± 1.4
Weight SDS )1.08 ± 0.86 )0.37 ± 0.98 )1.96 ± 1.15
Length SDS )0.80 ± 0.91 )0.41 ± 0.92 )1.21 ± 1.11
Radius shaft
*
Bone mineral
content (g⁄cm) 0.056 ± 0.014 0.068 ± 0.018 0.087 ± 0.022
Bone width (cm) 0.374 ± 0.066 0.470 ± 0.067 0.594 ± 0.092
Whole body
†
Bone mineral
content (g) 50.9 ± 11.6 89.5 ± 21.4 169.6 ± 35.1
Bone area (cm
2) 105 ± 20 177 ± 34 279 ± 50
Data are mean ± SD.
SDS, standard deviation score relative to British reference data (14).
*n ¼ 116, 118, 96 at 2, 13 and 52 weeks, respectively.
†n ¼ 44, 47, 52 at 2, 13 and 52 weeks, respectively.
Figure 1 Lack of a signiﬁcant relationship between infant birthweight and
maternal vitamin D status at 20 weeks of pregnancy (p ¼ 0.8). Multiple regres-
sion model included season, maternal height, weight, weight gain, supplement
group and sex of the infant.
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ﬁt for foetal and infant growth or bone mineral accrual in
aiming to increase the vitamin D status of individual
mothers during pregnancy above 50 or 80 nmol⁄L.
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